rivaroxaban Clinical Research Trials

featured

EINSTEIN CHOICE

352 views
08 Nov, 2020
1 location

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

support the use of intraprocedural anticoagulation to mitigate the risk of radial artery occlusion however the role of post-procedural anticoagulation has not been previously evaluated. Rivaroxaban is a

11 views
26 Jan, 2021
1 location

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events Hospitalization and Death in Medically Ill Outpatients With Acute Symptomatic Coronavirus Disease 2019 (COVID-19) Infection

The purpose of this study is to evaluate whether rivaroxaban reduces the risk of a composite endpoint of major venous and arterial thrombotic events, all-cause hospitalization, and all-cause

nasopharyngeal swab

cancer

coronavirus infection

covid-19

ageusia

0 views
17 Jan, 2021
13 locations

Study of Rivaroxaban for CeREbral Venous Thrombosis

SECRET examines the safety of rivaroxaban versus standard-of-care for treatment of symptomatic cerebral venous thrombosis, initiated within 14 days of diagnosis.

1 views
25 Jan, 2021
13 locations

Rivaroxaban or Aspirin for Biological Aortic Prosthesis

recipient endothelium. There are no conclusive studies of anticoagulation and the investigators have shown stroke to be a common complication. Guidelines have variably recommended aspirin or rivaroxaban for

aspirin

rivaroxaban 10 mg

infarct

stroke

clot

0 views
22 Jan, 2021
3 locations

Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

> Rivaroxaban, a direct coagulation factor a inhibitor, blocks the formation of the clot. ROCKET-AF study has shown that the efficacy of rivaroxaban is not inferior to that of warfarin in AF patients on stroke

deficit

anticoagulant therapy

anticoagulants

infarct

warfarin

13 views
23 Jan, 2021
1 location

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

provide comprehensive CKD care. Approximately 2000 participants will be recruited. The TRACK trial will assess a strategy of administering low dose rivaroxaban to reduce the risk of major adverse

0 views
02 Jan, 2021
20 locations

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Apixaban and rivaroxaban have been compared to standard therapy for treatment of acute symptomatic venous thromboembolism (VTE) in randomized controlled trials (RCTs), and are both approved by

venous thromboembolism

apixaban

probe

rivaroxaban

anticoagulants

285 views
18 Jan, 2021
21 locations

Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis

isolated distal deep vein thrombosis of the leg treated with a standard (12 weeks) or with a shorter (6 weeks) duration of therapy with rivaroxaban.

deep vein thrombosis